Kidney cancer affects over 80,000 Americans annually, with renal cell carcinoma as the dominant type. Benjamin R. Lee, MD, MBA, outlines current AUA guideline recommendations, including when to…
Dr. Allison Betof Warner from Stanford University joins Rahul Gosain, MD and Rohit Gosain, MD, on the Oncology Brothers podcast to discuss melanoma treatment. The conversation covers the…
NEW YORK (Reuters Health) – Use of the radioprotective agent amifostine to reduce xerostomia and other side effects in cancer patients undergoing radiation therapy does not decrease survival,…
NEW YORK (Reuters health) – Among premenopausal women treated for hormone-responsive breast cancer with adjuvant anastrozole, body mass index (BMI) has a significant impact on outcomes, an Austrian…
NEW YORK (Reuters Health) – Roughly one-third of venous thromboembolism (VTE) events that occur in patients who’ve had surgery for cancer happen after they leave the hospital, with…
NEW YORK (Reuters Health) – For children and adolescents with conditions that require frequent placement of intravenous lines, administration of 50% nitrous oxide makes the process of IV…
NEW YORK (Reuters Health) – Ovarian suppression, using a luteinizing hormone-releasing hormone agonist, during neoadjuvant chemotherapy for breast cancer in premenopausal women does not help preserve subsequent ovarian…
Teresa L. Knight, MD, FACOG, Chief Medical Officer of the Women’s Health Specialists of Saint Louis, discusses the risks of inherited breast cancer gene mutations. To learn more…
NEW YORK (Reuters Health) –The theoretical advantages of stereotactic radiation therapy for treating tumors in the body have yet to be confirmed clinically — despite its widespread use…
NEW YORK (Reuters Health) – Long-term results confirm that use of neoadjuvant chemotherapy in treating muscle-invasive cancer of the bladder confers a significant survival advantage, an international collaborative…
NEW YORK (Reuters Health) – Contrary to previous findings, patients with advanced cancer do not have significantly improved survival when they are treated with a low-molecular-weight heparin, European…
NEW YORK (Reuters Health) – The combination of etanercept and cyclophosphamide might be a risky one in patients with Wegener’s Granulomatosis, especially with those who have long-term, chronic…
